{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:49:56Z","timestamp":1785804596610,"version":"3.56.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011541","name":"U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA190294"],"award-info":[{"award-number":["R01CA190294"]}],"id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH085802"],"award-info":[{"award-number":["R01MH085802"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH133066"],"award-info":[{"award-number":["R01MH133066"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS130361"],"award-info":[{"award-number":["R01NS130361"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41380-026-03492-9","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:41:03Z","timestamp":1771425663000},"page":"3662-3673","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["miR126-mediated alteration of vascular integrity in Rett syndrome"],"prefix":"10.1038","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-0629","authenticated-orcid":false,"given":"Tatsuya","family":"Osaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-7722","authenticated-orcid":false,"given":"Zhengpeng","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1767-6854","authenticated-orcid":false,"given":"Koji","family":"Haratani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylliah","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9288-5285","authenticated-orcid":false,"given":"Marco","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5422-4275","authenticated-orcid":false,"given":"David A.","family":"Barbie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7232-304X","authenticated-orcid":false,"given":"Roger D.","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2442-5671","authenticated-orcid":false,"given":"Mriganka","family":"Sur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"3492_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrg3897","volume":"16","author":"MJ Lyst","year":"2015","unstructured":"Lyst MJ, Bird A. Rett syndrome: a complex disorder with simple roots. Nat Rev Genet. 2015;16:261\u201375.","journal-title":"Nat Rev Genet"},{"key":"3492_CR2","doi-asserted-by":"publisher","first-page":"7951","DOI":"10.1523\/JNEUROSCI.0169-11.2011","volume":"31","author":"RC Samaco","year":"2011","unstructured":"Samaco RC, Neul JL. Complexities of Rett Syndrome and MeCP2. J Neurosci. 2011;31:7951\u20139.","journal-title":"J Neurosci"},{"key":"3492_CR3","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour M, Zoghbi HY. The story of Rett syndrome: from clinic to neurobiology. Neuron. 2007;56:422\u201337.","journal-title":"Neuron"},{"key":"3492_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay5947","volume":"367","author":"E Sj\u00f6stedt","year":"2020","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L, Karlsson M, Mitsios N, Adori C, et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science. 2020;367:eaay5947.","journal-title":"Science"},{"key":"3492_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abh2169","volume":"7","author":"M Karlsson","year":"2021","unstructured":"Karlsson M, Zhang C, M\u00e9ar L, Zhong W, Digre A, Katona B, et al. A single\u2013cell type transcriptomics map of human tissues. Sci Adv. 2021;7:eabh2169.","journal-title":"Sci Adv"},{"key":"3492_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1600-0404.1997.tb00067.x","volume":"95","author":"R Lappalainen","year":"1997","unstructured":"Lappalainen R, Liewendahl K, Sainio K, Nikkinen P, Riikonen RS. Brain perfusion SPECT and EEG findings in Rett syndrome. Acta Neurol Scand. 1997;95:44\u201350.","journal-title":"Acta Neurol Scand"},{"key":"3492_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/CH-131707","volume":"54","author":"G Bianciardi","year":"2013","unstructured":"Bianciardi G, Acampa M, Lamberti I, Sartini S, Servi M, Biagi F, et al. Microvascular abnormalities in Rett syndrome. Clin Hemorheol Microcirc. 2013;54:109\u201313.","journal-title":"Clin Hemorheol Microcirc"},{"key":"3492_CR8","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/bdr2.1180","volume":"109","author":"KS Saili","year":"2017","unstructured":"Saili KS, Zurlinden TJ, Schwab AJ, Silvin A, Baker NC, Hunter ES, et al. Blood-brain barrier development: Systems modeling and predictive toxicology. Birth Defects Res. 2017;109:1680\u2013710.","journal-title":"Birth Defects Res"},{"key":"3492_CR9","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nature09513","volume":"468","author":"R Daneman","year":"2010","unstructured":"Daneman R, Zhou L, Kebede AA, Barres BA. Pericytes are required for blood\u2013brain barrier integrity during embryogenesis. Nature. 2010;468:562\u20136.","journal-title":"Nature"},{"key":"3492_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.neuro.2011.12.009","volume":"33","author":"CJ Ek","year":"2012","unstructured":"Ek CJ, Dziegielewska KM, Habgood MD, Saunders NR. Barriers in the developing brain and Neurotoxicology. Neurotoxicology. 2012;33:586\u2013604.","journal-title":"Neurotoxicology"},{"key":"3492_CR11","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nbt0909-804","volume":"27","author":"NR Saunders","year":"2009","unstructured":"Saunders NR, Joakim Ek C, Dziegielewska KM. The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9. Nat Biotechnol. 2009;27:804\u20135.","journal-title":"Nat Biotechnol"},{"key":"3492_CR12","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/nm.3407","volume":"19","author":"B Obermeier","year":"2013","unstructured":"Obermeier B, Daneman R, Ransohoff RM. Development, maintenance and disruption of the blood-brain barrier. Nat Med. 2013;19:1584\u201396.","journal-title":"Nat Med"},{"key":"3492_CR13","first-page":"49","volume":"34","author":"M Aschner","year":"2017","unstructured":"Aschner M, Ceccatelli S, Daneshian M, Fritsche E, Hasiwa N, Hartung T, et al. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX. 2017;34:49\u201374.","journal-title":"ALTEX"},{"key":"3492_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/10408444.2014.981331","volume":"45","author":"A Bal-Price","year":"2015","unstructured":"Bal-Price A, Crofton KM, Sachana M, Shafer TJ, Behl M, Forsby A, et al. Putative adverse outcome pathways relevant to neurotoxicity. Crit Rev Toxicol. 2015;45:83\u201391.","journal-title":"Crit Rev Toxicol"},{"key":"3492_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.devcel.2010.05.006","volume":"18","author":"M Corada","year":"2010","unstructured":"Corada M, Nyqvist D, Orsenigo F, Caprini A, Giampietro C, Taketo MM, et al. The Wnt\/beta-catenin pathway modulates vascular remodeling and specification by upregulating Dll4\/Notch signaling. Dev Cell. 2010;18:938\u201349.","journal-title":"Dev Cell"},{"key":"3492_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nature03987","volume":"437","author":"SM Weis","year":"2005","unstructured":"Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature. 2005;437:497\u2013504.","journal-title":"Nature"},{"key":"3492_CR17","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci. 2011;12:723\u201338.","journal-title":"Nat Rev Neurosci"},{"key":"3492_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV. Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nature Reviews Neurology. 2018;14:133\u201350.","journal-title":"Nature Reviews Neurology"},{"key":"3492_CR19","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/jcbfm.2015.32","volume":"35","author":"MT Gray","year":"2015","unstructured":"Gray MT, Woulfe JM. Striatal blood\u2013brain barrier permeability in Parkinson\u2019S disease. J Cereb Blood Flow Metab. 2015;35:747\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3492_CR20","doi-asserted-by":"publisher","first-page":"17579","DOI":"10.1074\/jbc.M112.434787","volume":"288","author":"R Shaltiel-Karyo","year":"2013","unstructured":"Shaltiel-Karyo R, Frenkel-Pinter M, Rockenstein E, Patrick C, Levy-Sakin M, Schiller A, et al. A blood-brain barrier (BBB) disrupter is also a potent \u03b1-synuclein (\u03b1-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD) *. Journal of Biological Chemistry. 2013;288:17579\u201388.","journal-title":"Journal of Biological Chemistry"},{"key":"3492_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1144036","volume":"15","author":"RL Lee","year":"2023","unstructured":"Lee RL, Funk KE. Imaging blood-brain barrier disruption in neuroinflammation and Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1144036.","journal-title":"Front Aging Neurosci"},{"key":"3492_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/biom13040606","volume":"13","author":"G Pepe","year":"2023","unstructured":"Pepe G, Fioriniello S, Marracino F, Capocci L, Maglione V, D\u2019Esposito M, et al. Blood\u2013brain barrier integrity is perturbed in a Mecp2-null mouse model of rett syndrome. Biomolecules. 2023;13:606.","journal-title":"Biomolecules"},{"key":"3492_CR23","doi-asserted-by":"publisher","first-page":"e64863","DOI":"10.1371\/journal.pone.0064863","volume":"8","author":"A Panighini","year":"2013","unstructured":"Panighini A, Duranti E, Santini F, Maffei M, Pizzorusso T, Funel N, et al. Vascular dysfunction in a mouse model of rett syndrome and effects of curcumin treatment. PLoS ONE. 2013;8:e64863.","journal-title":"PLoS ONE"},{"key":"3492_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s13229-017-0174-4","volume":"8","author":"NL Pacheco","year":"2017","unstructured":"Pacheco NL, Heaven MR, Holt LM, Crossman DK, Boggio KJ, Shaffer SA, et al. RNA sequencing and proteomics approaches reveal novel deficits in the cortex of Mecp2-deficient mice, a model for Rett syndrome. Mol Autism. 2017;8:56.","journal-title":"Mol Autism"},{"key":"3492_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/nn.3434","volume":"16","author":"MJ Lyst","year":"2013","unstructured":"Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR\/SMRT co-repressor. Nat Neurosci. 2013;16:898\u2013902.","journal-title":"Nat Neurosci"},{"key":"3492_CR26","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/gbb.12070","volume":"12","author":"LR Schaevitz","year":"2013","unstructured":"Schaevitz LR, G\u00f3mez NB, Zhen DP, Berger-Sweeney JE. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits. Genes Brain Behav. 2013;12:732\u201340.","journal-title":"Genes Brain Behav"},{"key":"3492_CR27","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1073\/pnas.0608056104","volume":"104","author":"X Nan","year":"2007","unstructured":"Nan X, Hou J, Maclean A, Nasir J, Lafuente MJ, Shu X, et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci USA. 2007;104:2709\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3492_CR28","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10456-024-09937-5","volume":"27","author":"AC Luo","year":"2024","unstructured":"Luo AC, Wang J, Wang K, Zhu Y, Gong L, Lee U, et al. A streamlined method to generate endothelial cells from human pluripotent stem cells via transient doxycycline-inducible ETV2 activation. Angiogenesis. 2024;27:779\u201395.","journal-title":"Angiogenesis"},{"key":"3492_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41586-020-2712-z","volume":"585","author":"B Palikuqi","year":"2020","unstructured":"Palikuqi B, Nguyen D-HT, Li G, Schreiner R, Pellegata AF, Liu Y, et al. Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis. Nature. 2020;585:426\u201332.","journal-title":"Nature"},{"key":"3492_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.yexcr.2017.06.003","volume":"358","author":"C Cerutti","year":"2017","unstructured":"Cerutti C, Ridley AJ. Endothelial cell-cell adhesion and signaling. Exp Cell Res. 2017;358:31\u201338.","journal-title":"Exp Cell Res"},{"key":"3492_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1161\/CIRCRESAHA.116.306534","volume":"120","author":"YA Komarova","year":"2017","unstructured":"Komarova YA, Kruse K, Mehta D, Malik AB. Protein interactions at endothelial junctions and signaling mechanisms regulating endothelial permeability. Circ Res. 2017;120:179\u2013206.","journal-title":"Circ Res"},{"key":"3492_CR32","doi-asserted-by":"publisher","first-page":"199","DOI":"10.2174\/1566524014666140128104541","volume":"14","author":"RJ Marjoram","year":"2014","unstructured":"Marjoram RJ, Lessey EC, Burridge K. Regulation of RhoA activity by adhesion molecules and mechanotransduction. Curr Mol Med. 2014;14:199\u2013208.","journal-title":"Curr Mol Med"},{"key":"3492_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/CIRCRESAHA.122.322332","volume":"132","author":"J Aman","year":"2023","unstructured":"Aman J, Margadant C. Integrin-dependent cell\u2013matrix adhesion in endothelial health and disease. Circ Res. 2023;132:355\u201378.","journal-title":"Circ Res"},{"key":"3492_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3492_CR35","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn3879","volume":"16","author":"O Issler","year":"2015","unstructured":"Issler O, Chen A. Determining the role of microRNAs in psychiatric disorders. Nat Rev Neurosci. 2015;16:201\u201312.","journal-title":"Nat Rev Neurosci"},{"key":"3492_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1083\/jcb.200908151","volume":"189","author":"KE Szulwach","year":"2010","unstructured":"Szulwach KE, Li X, Smrt RD, Li Y, Luo Y, Lin L, et al. Cross talk between microRNA and epigenetic regulation in adult neurogenesis. Journal of Cell Biology. 2010;189:127\u201341.","journal-title":"Journal of Cell Biology"},{"key":"3492_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4161\/epi.5.7.13055","volume":"5","author":"RG Urdinguio","year":"2010","unstructured":"Urdinguio RG, Fern\u00e1ndez AF, Lopez-Nieva P, Rossi S, Huertas D, Kulis M, et al. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics. 2010;5:656\u201363.","journal-title":"Epigenetics"},{"key":"3492_CR38","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1016\/j.celrep.2015.08.028","volume":"12","author":"K Tsujimura","year":"2015","unstructured":"Tsujimura K, Irie K, Nakashima H, Egashira Y, Fukao Y, Fujiwara M, et al. miR-199a links MeCP2 with mTOR signaling and its dysregulation leads to rett syndrome phenotypes. Cell Reports. 2015;12:1887\u2013901.","journal-title":"Cell Reports"},{"key":"3492_CR39","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1111\/j.1582-4934.2008.00613.x","volume":"13","author":"C van Solingen","year":"2009","unstructured":"van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM, et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med. 2009;13:1577\u201385.","journal-title":"J Cell Mol Med"},{"key":"3492_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1629-z","volume":"20","author":"W Liu","year":"2019","unstructured":"Liu W, Wang X. Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data. Genome Biol. 2019;20:18.","journal-title":"Genome Biol"},{"key":"3492_CR41","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrd.2016.278","volume":"16","author":"P Saharinen","year":"2017","unstructured":"Saharinen P, Eklund L, Alitalo K. Therapeutic targeting of the angiopoietin\u2013TIE pathway. Nat Rev Drug Discov. 2017;16:635\u201361.","journal-title":"Nat Rev Drug Discov"},{"key":"3492_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm2639","volume":"10","author":"HG Augustin","year":"2009","unstructured":"Augustin HG, Young Koh G, Thurston G, Alitalo K. Control of vascular morphogenesis and homeostasis through the angiopoietin\u2013Tie system. Nat Rev Mol Cell Biol. 2009;10:165\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3492_CR43","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1248\/bpb.b21-00929","volume":"45","author":"H Zhang","year":"2022","unstructured":"Zhang H, Yamaguchi T, Kokubu Y, Kawabata K. Transient ETV2 expression promotes the generation of mature endothelial cells from human pluripotent stem cells. Biol Pharm Bull. 2022;45:483\u201390.","journal-title":"Biol Pharm Bull"},{"key":"3492_CR44","doi-asserted-by":"publisher","first-page":"eaba7606","DOI":"10.1126\/sciadv.aba7606","volume":"6","author":"K Wang","year":"2020","unstructured":"Wang K, Lin R-Z, Hong X, Ng AH, Lee CN, Neumeyer J, et al. Robust differentiation of human pluripotent stem cells into endothelial cells via temporal modulation of ETV2 with modified mRNA. Sci Adv. 2020;6:eaba7606.","journal-title":"Sci Adv"},{"key":"3492_CR45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.07.014","volume":"180","author":"M Campisi","year":"2018","unstructured":"Campisi M, Shin Y, Osaki T, Hajal C, Chiono V, Kamm RD. 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials. 2018;180:117\u201329.","journal-title":"Biomaterials"},{"key":"3492_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-23512-1","volume":"8","author":"T Osaki","year":"2018","unstructured":"Osaki T, Sivathanu V, Kamm RD. Engineered 3D vascular and neuronal networks in a microfluidic platform. Sci Rep. 2018;8:5168.","journal-title":"Sci Rep"},{"key":"3492_CR47","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biomaterials.2019.05.022","volume":"212","author":"GS Offeddu","year":"2019","unstructured":"Offeddu GS, Haase K, Gillrie MR, Li R, Morozova O, Hickman D, et al. An on-chip model of protein paracellular and transcellular permeability in the microcirculation. Biomaterials. 2019;212:115\u201325.","journal-title":"Biomaterials"},{"key":"3492_CR48","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41596-021-00635-w","volume":"17","author":"C Hajal","year":"2022","unstructured":"Hajal C, Offeddu GS, Shin Y, Zhang S, Morozova O, Hickman D, et al. Engineered human blood\u2013brain barrier microfluidic model for vascular permeability analyses. Nat Protoc. 2022;17:95\u2013128.","journal-title":"Nat Protoc"},{"key":"3492_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1080\/10409230290771546","volume":"37","author":"PE Van den Steen","year":"2002","unstructured":"Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol. 2002;37:375\u2013536.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"3492_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Circ Res. 2003;92:827\u201339.","journal-title":"Circ Res"},{"key":"3492_CR51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.bbamcr.2009.07.004","volume":"1803","author":"M Fanjul-Fern\u00e1ndez","year":"2010","unstructured":"Fanjul-Fern\u00e1ndez M, Folgueras AR, Cabrera S, L\u00f3pez-Ot\u00edn C. Matrix metalloproteinases: Evolution, gene regulation and functional analysis in mouse models. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 2010;1803:3\u201319.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"},{"key":"3492_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","volume":"15","author":"S Wang","year":"2008","unstructured":"Wang S, Aurora AB, Johnson BA, Qi X, McAnally J, Hill JA, et al. The endothelial-specific MicroRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell. 2008;15:261\u201371.","journal-title":"Dev Cell"},{"key":"3492_CR53","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1038\/s41551-024-01229-z","volume":"8","author":"L Wang","year":"2024","unstructured":"Wang L, Xu W, Zhang S, Gundberg GC, Zheng CR, Wan Z, et al. Sensing and guiding cell-state transitions by using genetically encoded endoribonuclease-mediated microRNA sensors. Nature Biomedical Engineering. 2024;8:1730\u201343.","journal-title":"Nature Biomedical Engineering"},{"key":"3492_CR54","doi-asserted-by":"publisher","first-page":"10","DOI":"10.20517\/2347-8659.2018.01","volume":"5","author":"M-J Qu","year":"2018","unstructured":"Qu M-J, Pan J-J, Shi X-J, Zhang Z-J, Tang Y-H, Yang G-Y. MicroRNA-126 is a prospective target for vascular disease. Neuroimmunology and Neuroinflammation. 2018;5:10.","journal-title":"Neuroimmunology and Neuroinflammation"},{"key":"3492_CR55","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee Y, Kim M, Han J, Yeom KH, Lee S, Baek SH, et al. MicroRNA genes are transcribed by RNA polymerase II. EMBO J. 2004;23:4051\u201360.","journal-title":"EMBO J"},{"key":"3492_CR56","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.neuron.2024.04.007","volume":"112","author":"Y Liu","year":"2024","unstructured":"Liu Y, Flamier A, Bell GW, Diao AJ, Whitfield TW, Wang H-C, et al. MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. Neuron. 2024;112:1943\u2013.e10.","journal-title":"Neuron"},{"key":"3492_CR57","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.devcel.2014.01.032","volume":"28","author":"T-L Cheng","year":"2014","unstructured":"Cheng T-L, Wang Z, Liao Q, Zhu Y, Zhou W-H, Xu W, et al. MeCP2 suppresses nuclear MicroRNA processing and dendritic growth by regulating the DGCR8\/Drosha complex. Dev Cell. 2014;28:547\u201360.","journal-title":"Dev Cell"},{"key":"3492_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109124","volume":"35","author":"H Nakashima","year":"2021","unstructured":"Nakashima H, Tsujimura K, Irie K, Imamura T, Trujillo CA, Ishizu M, et al. MeCP2 controls neural stem cell fate specification through miR-199a-mediated inhibition of BMP-Smad signaling. Cell Reports. 2021;35:109124.","journal-title":"Cell Reports"},{"key":"3492_CR59","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/mp.2017.86","volume":"23","author":"N Mellios","year":"2018","unstructured":"Mellios N, Feldman DA, Sheridan SD, Ip JPK, Kwok S, Amoah SK, et al. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling. Mol Psychiatry. 2018;23:1051\u201365.","journal-title":"Mol Psychiatry"},{"key":"3492_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1161\/CIRCRESAHA.115.307408","volume":"118","author":"A Chamorro-Jorganes","year":"2016","unstructured":"Chamorro-Jorganes A, Lee MY, Araldi E, Landskroner-Eiger S, Fern\u00e1ndez-Fuertes M, Sahraei M, et al. VEGF-induced expression of miR-17\u201392 cluster in endothelial cells is mediated by ERK\/ELK1 activation and regulates angiogenesis. Circ Res. 2016;118:38\u201347.","journal-title":"Circ Res"},{"key":"3492_CR61","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1161\/STROKEAHA.119.027531","volume":"51","author":"J Pan","year":"2020","unstructured":"Pan J, Qu M, Li Y, Wang L, Zhang L, Wang Y, et al. MicroRNA-126-3p\/-5p Overexpression attenuates blood-brain barrier disruption in a mouse model of middle cerebral artery occlusion. Stroke. 2020;51:619\u201327.","journal-title":"Stroke"},{"key":"3492_CR62","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1073\/pnas.0707493105","volume":"105","author":"TA Harris","year":"2008","unstructured":"Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proceedings of the National Academy of Sciences. 2008;105:1516\u201321.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"3492_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/srep41316","volume":"7","author":"A Di Pardo","year":"2017","unstructured":"Di Pardo A, Amico E, Scalabr\u00ec F, Pepe G, Castaldo S, Elifani F, et al. Impairment of blood-brain barrier is an early event in R6\/2 mouse model of Huntington Disease. Sci Rep. 2017;7:41316.","journal-title":"Sci Rep"},{"key":"3492_CR64","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","volume":"1","author":"G Barisano","year":"2022","unstructured":"Barisano G, Montagne A, Kisler K, Schneider JA, Wardlaw JM, Zlokovic BV. Blood\u2013brain barrier link to human cognitive impairment and Alzheimer\u2019s disease. Nature Cardiovascular Research. 2022;1:108\u201315.","journal-title":"Nature Cardiovascular Research"},{"key":"3492_CR65","doi-asserted-by":"publisher","first-page":"15271","DOI":"10.3390\/ijms232315271","volume":"23","author":"A Arag\u00f3n-Gonz\u00e1lez","year":"2022","unstructured":"Arag\u00f3n-Gonz\u00e1lez A, Shaw PJ, Ferraiuolo L. Blood-brain barrier disruption and its involvement in neurodevelopmental and neurodegenerative disorders. Int J Mol Sci. 2022;23:15271.","journal-title":"Int J Mol Sci"},{"key":"3492_CR66","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.neuron.2020.09.002","volume":"108","author":"RS Pulido","year":"2020","unstructured":"Pulido RS, Munji RN, Chan TC, Quirk CR, Weiner GA, Weger BD, et al. Neuronal activity regulates blood-brain barrier efflux transport through endothelial circadian genes. Neuron. 2020;108:937\u2013e937.","journal-title":"Neuron"},{"key":"3492_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43689-3","volume":"9","author":"M Alique","year":"2019","unstructured":"Alique M, Bodega G, Giannarelli C, Carracedo J, Ram\u00edrez R. MicroRNA-126 regulates Hypoxia-Inducible Factor-1\u03b1 which inhibited migration, proliferation, and angiogenesis in replicative endothelial senescence. Sci Rep. 2019;9:7381.","journal-title":"Sci Rep"},{"key":"3492_CR68","doi-asserted-by":"publisher","first-page":"6032","DOI":"10.1111\/jcmm.16460","volume":"25","author":"Bassand","year":"2021","unstructured":"Bassand, Metzinger L K, Na\u00efm M, Mouhoubi N, Haddad O, Assoun V, et al. miR-126-3p is essential for CXCL12-induced angiogenesis. J Cell Mol Med. 2021;25:6032\u201345.","journal-title":"J Cell Mol Med"},{"key":"3492_CR69","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2016.05.007","volume":"97","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov DA, Orekhov AN, Bobryshev YV. The role of miR-126 in embryonic angiogenesis, adult vascular homeostasis, and vascular repair and its alterations in atherosclerotic disease. J Mol Cell Cardiol. 2016;97:47\u201355.","journal-title":"J Mol Cell Cardiol"},{"key":"3492_CR70","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.2174\/0929867329666220830100530","volume":"30","author":"P Theofilis","year":"2023","unstructured":"Theofilis P, Oikonomou E, Vogiatzi G, Sagris M, Antonopoulos AS, Siasos G, et al. The Role of MicroRNA-126 in atherosclerotic cardiovascular diseases. Curr Med Chem. 2023;30:1902\u201321.","journal-title":"Curr Med Chem"},{"key":"3492_CR71","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.3892\/mmr.2017.6952","volume":"16","author":"XW Cheng","year":"2017","unstructured":"Cheng XW, Wan YF, Zhou Q, Wang Y, Zhu HQ. MicroRNA\u2011126 inhibits endothelial permeability and apoptosis in apolipoprotein E\u2011knockout mice fed a high\u2011fat diet. Mol Med Rep. 2017;16:3061\u20138.","journal-title":"Mol Med Rep"},{"key":"3492_CR72","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184:5635\u2013e5629.","journal-title":"Cell"},{"key":"3492_CR73","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.05005","volume":"4","author":"V Agarwal","year":"2015","unstructured":"Agarwal V, Bell GW, Nam J-W, Bartel DP. Predicting effective microRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.","journal-title":"eLife"},{"key":"3492_CR74","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/cyto.a.22239","volume":"83A","author":"C Terryn","year":"2013","unstructured":"Terryn C, Sellami M, Fichel C, Diebold M-D, Gangloff S, Le Naour R, et al. Rapid method of quantification of tight-junction organization using image analysis. Cytometry Part A. 2013;83A:235\u201341.","journal-title":"Cytometry Part A"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03492-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03492-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T08:03:56Z","timestamp":1781510636000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-026-03492-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":74,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["3492"],"URL":"https:\/\/doi.org\/10.1038\/s41380-026-03492-9","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"4 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RDK is a co-founder of AIM Biotech, a company that markets microfluidic technologies and receives research support from Amgen, Abbvie, Boehringer-Ingelheim, Novartis, Daiichi-Sankyo, Roche, Takeda, Eisai, EMD Serono, and Visterra. DAB is a consultant for N of One\/Qiagen and Exo Therapeutics, is a founder and shareholder in Xsphera Biosciences, has received honoraria from Merck, H3 Biomedicine\/Esai, EMD Serono, Gilead Sciences, Abbvie, and Madalon Consulting, and research grants from BMS, Takeda, Novartis, Gilead, and Lilly and Daiichi Sankyo.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The use of human iPS cells was reviewed and approved by Picower Institute for learning and memory, Massachusetts Institute of Technology. The human iPS cells were handled in accordance with approved protocols.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}